The field of myeloma and chronic lymphocytic leukemia is changing at pace. Due to significant advances in technology, particularly in genomics, our understanding of normal and neoplastic haemopoiesis is constantly improving. However, the real challenge is how these technological advances and genomic information can be transferred from the laboratory to the clinical management of the…